Nomir Medical Announces FDA Clearance for Noveon NaiLaser

Press release: Nomir Medical Announces FDA Clearance for Noveon NaiLaser Quote: WOODMERE, N.Y., March 13, 2014; Nomir Medical Technologies, Inc., the world leader in antimicrobial photobiology, today announced that the US Food and Drug Administration has granted clearance to the company’s Noveon NaiLaser for the treatment of onychomycosis (toenail fungus).

Continued here:
Nomir Medical Announces FDA Clearance for Noveon NaiLaser

This entry was posted in Podiatry Arena. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *